DEFA14A ·Filed Apr 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine annual meeting with no material changes. Monitor for any unexpected shareholder proposals or voting outcomes, but no immediate trading implications.
Final — all horizons settled through T+60d
STRO ▼ -35.14% at T+60d
NEUTRAL call ✗ call lost -35.14% · α vs SPY -40.16% · entry $34.83 → $22.59
T+1d
-4.31%
call -4.31% · α -5.09%
$33.33
settled 5mo ago
T+5d
+1.61%
call +1.61% · α +0.13%
$35.39
settled 5mo ago
T+20d
-10.62%
call -10.62% · α -15.26%
$31.13
settled 5mo ago
T+60d
-35.14%
call -35.14% · α -40.16%
$22.59
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Sutro Biopharma is holding its annual shareholder meeting to elect directors, ratify auditors, and approve executive compensation. This is a routine corporate governance filing with no material financial or strategic changes.
Key Facts
- Sutro Biopharma is holding its annual shareholder meeting on June 5, 2026
- Shareholders will vote on the election of Class II directors (Jane Chung, Connie Matsui, James Panek)
- Shareholders will vote to ratify Ernst & Young LLP as the independent auditor
- Shareholders will vote on a non-binding advisory vote on executive compensation
Financial Impact
No material financial impact from this filing
none
Risk Factors
- None identified from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-170441 |
| Document: 0001193125-26-170441-index-headers.html | 0001193125-26-170441 |
| Document: 0001193125-26-170441-index.html | 0001193125-26-170441 |
| Document: 0001193125-26-170441.txt | 0001193125-26-170441 |
6 reports for STRO
75% Hit rate best @ T+20▲ +50.74%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 7w ago | 8-K | $21.30 $17.83 | ▼ −16.29% | ▼ −14.39% | $15.52 (−27.16%) |
Aug 12, 2026 7w ago | Press Release | $21.30 $17.83 | ▼ −16.29% | ▼ −14.39% | $15.52 (−27.16%) |
Apr 22, 2026 23w ago | DEFA14A | $34.83 $31.13 | ▼ −10.62% | ▼ −15.26% | $15.52 (−55.46%) |
Apr 19, 2026 23w ago | Press Release | $34.58 $34.48 | ▼ −0.29% | ▼ −4.49% | $15.52 (−55.13%) |
Mar 23, 2026 27w ago | S-3 | $23.57 $35.53 | ▼ −50.74% | ▼ −41.84% | $15.52 (+34.17%) |
Mar 23, 2026 27w ago | Press Release | $23.57 $35.53 | ▲ +50.74% | ▲ +41.84% | $15.52 (−34.17%) |
Showing 6 of 6
US Market Status
Market Open — Closes in 2h 55m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access